Evidence map›Paper›PMID 23764631›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2013

Preventing HIV infection in women.

Adaora A Adimora, Catalina Ramirez, Judith D Auerbach, Sevgi O Aral, Sally Hodder, Gina Wingood, Wafaa El-Sadr, Elizabeth A Bukusi, HIV Prevention Trials Network Women at Risk Committee

Registry-linked trialAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06022809 (Comparative Effectiveness of Individual Versus Group-level Interventions to Reduce HIV Risk Among African Immigrant Women), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06022809 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparative Effectiveness of Individual Versus Group-level Interventions to Reduce HIV Risk Among African Immigrant Women

TypeinterventionalSponsorMassachusetts General HospitalRan2023 to 2026Enrolled149ConditionsHIV, Other STIsArmsDada Kwa Dada (individual-level), DADA (group-level)
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.Journal of nanotechnology and materials science · 2017
    Article
  11. Article
  12. HIV pre-exposure prophylaxis for women.Journal of virus eradication · 2016
    Article
  13. Pilot Test of an Adapted, Evidence-Based HIV Sexual Risk Reduction Intervention for Homeless Women.Prevention science : the official journal of the Society for Prevention Research · 2016
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Women, drugs and HIV.The International journal on drug policy · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adaora A AdimoraDivision of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC 27599-7030, USA. adimora@med.unc.edu
Catalina Ramirez
Judith D Auerbach
Sevgi O Aral
Sally Hodder
Gina Wingood
Wafaa El-Sadr
Elizabeth A Bukusi
HIV Prevention Trials Network Women at Risk Committee

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
HIV Prevention trials Network (HPTN) Coordinating and Operations CenterU01AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI VERMUND, STEN H. · 2006 to 2010
$72.7M
K24 Mentoring Junior Faculty: The Minority ImperativeK24HD059358 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 2008 to 2012
$836k
NIAID NIH HHS U01 AI068619NIAID NIH HHS UM1 AI068619NICHD NIH HHS K24 HD059358
6 · The paper itself

Abstract

Although the number of new infections has declined recently, women still constitute almost half of the world's 34 million people with HIV infection, and HIV remains the leading cause of death among women of reproductive age. Prevention research has made considerable progress during the past few years in addressing the biological, behavioral, and social factors that influence women's vulnerability to HIV infection. Nevertheless, substantial work still must be performed to implement scientific advancements and to resolve many questions that remain. This article highlights some of the recent advances and persistent gaps in HIV prevention research for women and outlines key research and policy priorities.

Indexed as

Health Status DisparitiesWomen's HealthFemaleHealth PolicyHealth PrioritiesHealth PromotionHealth Services AccessibilityHIV InfectionsHumansPrevalenceResearchRisk FactorsSex FactorsSex OffensesSexual BehaviorSocial Change

Identifiers

PMID23764631
PMCPMC4084712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.